Metabolický syndrom a sympatický nervový systém: Je obstrukční spánková apnoe klíčem k pochopení?

Translated title of the contribution: Metabolic syndrome and sympathetic nervous system: Is obstructive sleep apnea a key to understanding?

Tomáš Kára, M. Souček, Š Kárová, J. Vítovec, Virend Somers

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Chronically increased sympathetic nervous system activity may contribute to the onset and progression of the metabolic syndrome. However, the primary cause of increased sympathetic activity in patients with this syndrome remains unclear. Obstructive sleep apnea has a high incidence in the general population and may be a significant independent risk factor for some cardiovascular diseases. Despite these considerations, obstructive sleep apnea remains generally underestimated phenomenon in both clinical practice as well as research. Data from clinical and basic research suggest that obstructive sleep apnea is associated with, and may contribute to, a significant increase in sympathetic activity, body weight and body fat, and systemic blood pressure. Obstructive sleep apnea is also associated with insulin and leptin resistance. Moreover, obstructive sleep apnea is linked with systemic inflammation, endothelial dysfunction, oxidative stress and a protrombotic state. Similarities in regulatory and metabolic abnormalities in obstructive sleep apnea and the metabolic syndrome, as well as the high prevalence of both metabolic syndrome and obstructive sleep apnea in the general population, suggest that obstructive sleep apnea may contribute to the pathophysiology and progression of the metabolic syndrome.

Original languageUndefined
Pages (from-to)53-61
Number of pages9
JournalVnitrni Lekarstvi
Volume51
Issue number1
StatePublished - 2005

Fingerprint

Sympathetic Nervous System
Obstructive Sleep Apnea
Leptin
Research
Population
Insulin Resistance
Adipose Tissue
Oxidative Stress
Cardiovascular Diseases
Body Weight
Blood Pressure
Inflammation
Incidence

Keywords

  • Metabolic syndrome
  • Nervous system sympathetic
  • Sleep
  • Sleep apnea obstructive
  • Syndrome X

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Metabolický syndrom a sympatický nervový systém : Je obstrukční spánková apnoe klíčem k pochopení? / Kára, Tomáš; Souček, M.; Kárová, Š; Vítovec, J.; Somers, Virend.

In: Vnitrni Lekarstvi, Vol. 51, No. 1, 2005, p. 53-61.

Research output: Contribution to journalArticle

Kára, Tomáš ; Souček, M. ; Kárová, Š ; Vítovec, J. ; Somers, Virend. / Metabolický syndrom a sympatický nervový systém : Je obstrukční spánková apnoe klíčem k pochopení?. In: Vnitrni Lekarstvi. 2005 ; Vol. 51, No. 1. pp. 53-61.
@article{4fc803f442a84e68b8648d05b33989b3,
title = "Metabolick{\'y} syndrom a sympatick{\'y} nervov{\'y} syst{\'e}m: Je obstrukčn{\'i} sp{\'a}nkov{\'a} apnoe kl{\'i}čem k pochopen{\'i}?",
abstract = "Chronically increased sympathetic nervous system activity may contribute to the onset and progression of the metabolic syndrome. However, the primary cause of increased sympathetic activity in patients with this syndrome remains unclear. Obstructive sleep apnea has a high incidence in the general population and may be a significant independent risk factor for some cardiovascular diseases. Despite these considerations, obstructive sleep apnea remains generally underestimated phenomenon in both clinical practice as well as research. Data from clinical and basic research suggest that obstructive sleep apnea is associated with, and may contribute to, a significant increase in sympathetic activity, body weight and body fat, and systemic blood pressure. Obstructive sleep apnea is also associated with insulin and leptin resistance. Moreover, obstructive sleep apnea is linked with systemic inflammation, endothelial dysfunction, oxidative stress and a protrombotic state. Similarities in regulatory and metabolic abnormalities in obstructive sleep apnea and the metabolic syndrome, as well as the high prevalence of both metabolic syndrome and obstructive sleep apnea in the general population, suggest that obstructive sleep apnea may contribute to the pathophysiology and progression of the metabolic syndrome.",
keywords = "Metabolic syndrome, Nervous system sympathetic, Sleep, Sleep apnea obstructive, Syndrome X",
author = "Tom{\'a}š K{\'a}ra and M. Souček and Š K{\'a}rov{\'a} and J. V{\'i}tovec and Virend Somers",
year = "2005",
language = "Undefined",
volume = "51",
pages = "53--61",
journal = "Vnitrni Lekarstvi",
issn = "0042-773X",
publisher = "Czech Medical Association J.E. Purkyne",
number = "1",

}

TY - JOUR

T1 - Metabolický syndrom a sympatický nervový systém

T2 - Je obstrukční spánková apnoe klíčem k pochopení?

AU - Kára, Tomáš

AU - Souček, M.

AU - Kárová, Š

AU - Vítovec, J.

AU - Somers, Virend

PY - 2005

Y1 - 2005

N2 - Chronically increased sympathetic nervous system activity may contribute to the onset and progression of the metabolic syndrome. However, the primary cause of increased sympathetic activity in patients with this syndrome remains unclear. Obstructive sleep apnea has a high incidence in the general population and may be a significant independent risk factor for some cardiovascular diseases. Despite these considerations, obstructive sleep apnea remains generally underestimated phenomenon in both clinical practice as well as research. Data from clinical and basic research suggest that obstructive sleep apnea is associated with, and may contribute to, a significant increase in sympathetic activity, body weight and body fat, and systemic blood pressure. Obstructive sleep apnea is also associated with insulin and leptin resistance. Moreover, obstructive sleep apnea is linked with systemic inflammation, endothelial dysfunction, oxidative stress and a protrombotic state. Similarities in regulatory and metabolic abnormalities in obstructive sleep apnea and the metabolic syndrome, as well as the high prevalence of both metabolic syndrome and obstructive sleep apnea in the general population, suggest that obstructive sleep apnea may contribute to the pathophysiology and progression of the metabolic syndrome.

AB - Chronically increased sympathetic nervous system activity may contribute to the onset and progression of the metabolic syndrome. However, the primary cause of increased sympathetic activity in patients with this syndrome remains unclear. Obstructive sleep apnea has a high incidence in the general population and may be a significant independent risk factor for some cardiovascular diseases. Despite these considerations, obstructive sleep apnea remains generally underestimated phenomenon in both clinical practice as well as research. Data from clinical and basic research suggest that obstructive sleep apnea is associated with, and may contribute to, a significant increase in sympathetic activity, body weight and body fat, and systemic blood pressure. Obstructive sleep apnea is also associated with insulin and leptin resistance. Moreover, obstructive sleep apnea is linked with systemic inflammation, endothelial dysfunction, oxidative stress and a protrombotic state. Similarities in regulatory and metabolic abnormalities in obstructive sleep apnea and the metabolic syndrome, as well as the high prevalence of both metabolic syndrome and obstructive sleep apnea in the general population, suggest that obstructive sleep apnea may contribute to the pathophysiology and progression of the metabolic syndrome.

KW - Metabolic syndrome

KW - Nervous system sympathetic

KW - Sleep

KW - Sleep apnea obstructive

KW - Syndrome X

UR - http://www.scopus.com/inward/record.url?scp=18744395638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18744395638&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:18744395638

VL - 51

SP - 53

EP - 61

JO - Vnitrni Lekarstvi

JF - Vnitrni Lekarstvi

SN - 0042-773X

IS - 1

ER -